As medical technology and research continues to make advancements, each New Year brings about fresh developments and new opportunities for diabetes management.
Read more : : https://asweetlife.org/6-diabetes-research-studies-to-watch-in-2019/
“The immune system is a sensory organ as much as it is an organ that’s protecting us,” notes John Wherry, chair of pharmacology, in a video marking the opening of the new Allen Institute for Immunology, a research organization for advancing the fundamental understanding of human immunology.
Read more : https://penntoday.upenn.edu/news/immune-profiling-new-opportunity-drug-development
The FDA recently released final guidance about the use of therapeutic proteins in developing biologics and biosimilars. "Immunogenicity Testing of Therapeutic Protein Products-developing and Validating Assays for Anti-Drug Antibody Detection" represents current FDA thinking about developing and validating assays for anti-drug antibody (ADA) detection.
Read more : https://www.centerforbiosimilars.com/news/fda-releases-final-guidance-on-immunogenicity-testing-for-biologics-and-biosimilars
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
Read more : https://eurekalert.org/pub_releases/2019-02/ki-nii020819.php
A number of regulatory incentives have stimulated a growing investment in orphan drug development by the biotech and pharmaceutical industry," says Dr. Terence Eagleton, Senior Medical Director at Medpace.
Read more : https://labiotech.eu/sponsored/orphan-drugs-development-future/